100 related articles for article (PubMed ID: 11160179)
1. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation.
Gahring L; Carlson NG; Meyer EL; Rogers SW
J Immunol; 2001 Feb; 166(3):1433-8. PubMed ID: 11160179
[TBL] [Abstract][Full Text] [Related]
2. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage.
Ganor Y; Teichberg VI; Levite M
J Immunol; 2007 Jan; 178(2):683-92. PubMed ID: 17202328
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
[TBL] [Abstract][Full Text] [Related]
4. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis?
Levite M; Hermelin A
J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
7. Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: insights into the association of specific autoantibodies with distinct disease phenotypes.
Ulanet DB; Flavahan NA; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2004 Jan; 50(1):233-41. PubMed ID: 14730621
[TBL] [Abstract][Full Text] [Related]
8. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response.
Ulanet DB; Torbenson M; Dang CV; Casciola-Rosen L; Rosen A
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12361-6. PubMed ID: 14519847
[TBL] [Abstract][Full Text] [Related]
9. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus.
Moga DE; Janssen WG; Vissavajjhala P; Czelusniak SM; Moran TM; Hof PR; Morrison JH
J Comp Neurol; 2003 Jul; 462(1):15-28. PubMed ID: 12761821
[TBL] [Abstract][Full Text] [Related]
11. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.
Whitney KD; McNamara JO
J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
[TBL] [Abstract][Full Text] [Related]
13. Rasmussen's encephalitis: an autoimmune disorder?
Andrews PI; McNamara JO
Curr Opin Neurobiol; 1996 Oct; 6(5):673-8. PubMed ID: 8937833
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to munc-18 in Rasmussen's encephalitis.
Yang R; Puranam RS; Butler LS; Qian WH; He XP; Moyer MB; Blackburn K; Andrews PI; McNamara JO
Neuron; 2000 Nov; 28(2):375-83. PubMed ID: 11144349
[TBL] [Abstract][Full Text] [Related]
15. Glutamate receptor GluR3 antibodies and death of cortical cells.
He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
[TBL] [Abstract][Full Text] [Related]
16. La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity.
Huang M; Ida H; Arima K; Nakamura H; Aramaki T; Fujikawa K; Tamai M; Kamachi M; Kawakami A; Yamasaki H; Origuchi T; Eguchi K
Life Sci; 2007 Oct; 81(19-20):1461-6. PubMed ID: 17945310
[TBL] [Abstract][Full Text] [Related]
17. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A
Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604
[TBL] [Abstract][Full Text] [Related]
18. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
Twyman RE; Gahring LC; Spiess J; Rogers SW
Neuron; 1995 Apr; 14(4):755-62. PubMed ID: 7718238
[TBL] [Abstract][Full Text] [Related]
19. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes.
Suidan HS; Bouvier J; Schaerer E; Stone SR; Monard D; Tschopp J
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8112-6. PubMed ID: 8058766
[TBL] [Abstract][Full Text] [Related]
20. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
